Clinical Trials Browser

Withdrawn × Interventional × Cognitive Dysfunction × Clear all

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT04942184 2022-11-01

STRATEGIES to Improve Memory in Alzheimer's Disease

Phase NA Withdrawn

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT04826315 2022-01-19

Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention

Phase NA Withdrawn

Psychological Well-Being, Communication, Neoplasms, Cognitive Dysfunction

NCT01691976 2020-11-20

Mild Cognitive Impairment in Men Following Androgen Deprivation

Phase NA Withdrawn

Genitourinary

Prostatic Neoplasms, Cognitive Dysfunction